MV Diagnostics Ltd develops and markets veterinary diagnostic test kits and reagents worldwide. The directors are Professor Gordon Harkiss and Dr Neil Watt. Gordon is an immunologist and is Emeritus Professor of Immunology at the University of Edinburgh, having recently left the Royal Dick School of Veterinary Studies. Neil is a veterinary pathologist, previously was a senior lecturer at the ‘Dick’ and currently does consultancy work for the Home Office on the regulation of animal experiments in addition to work with MV Diagnostics. Between us we have extensive experience in the pathogenesis, diagnosis, control and eradication of animal diseases. We have established SureTest Ltd as a wholly-owned subsidiary of MV Diagnostics Ltd to focus on advising Sure Farm Ltd on testing for TB and other diseases in a variety of species.
MV Diagnostics Ltd was incorporated in 1999 and the company’s main interests have been in Maedi Visna virus and Caprine Arthritis and Encephalitis virus (MVV/CAEV) and Caseous Lymphadenitis (CLA) in sheep and goats. We have been working closely with laboratories in Norway, the Netherlands, Spain, Finland, UK, USA, Canada and Italy to provide highly specific and sensitive tests for control and eradication of these diseases and have sold over 2 million tests. Our ELISA tests are the Elitest MVV/CAEV and Elitest CLA ELISAs and have been developed in collaboration with Hyphen BioMed SA, France. We have sold over 2 million tests worldwide to date.
We have an on-going collaboration with the Norwegian dairy industry through TINE SA (www.tine.no)Norway’s largest producer, distributor and exporter of dairy products. We have worked with TINE for the last 8 years on a ‘Healthier Goats’ project to eradicate CAEV and CLA from all of their dairy goats. When we started the project used our conventional Elitest ELISAs. Recently, in collaboration with Enfer, we have adapted these to a new multiplex format, and have added a third disease, so that we can test for CAEV, CLA and Johnes disease in one sample of serum or milk. TINE now use this MVD-Enferplex test in their ‘Healthier Goats’ project and have done over 25000 tests in the last 18 months. We are well on the way to eradicating these diseases from Norway aiming to have this completed by 2018. Recently we have developed a multiplex test for eight bovine diseases and TINE are using this to screen bulk milk for all 9000+ dairy herds in Norway.
Our collaboration with Enfer started about 2 years ago when we identified the potential of their multiplex system for a variety of diseases in the veterinary market. They already had a multiplex test for TB in cattle and were developing this for other species. We are working with them to validate the test system in different species and to extend and improve its capabilities with new antigens. We feel that being able to detect antibodies to TB will open up a variety of novel testing strategies which will significantly improve our ability to deal with this devastating disease.